CAChristabella Adine

Christabella Adine

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christabella Adine has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Bioengineered hydrogels enhance ex vivo preservation of patient-derived tumor explants for drug evaluation

    by Christabella Adine, Kanishka Fernando, Nicholas Ching Wei Ho, Hong Sheng Quah, Samantha Shu Wen Ho, Kenny Zhuoran Wu, Karen Wei Weng Teng, Camille Arcinas, Ling Li, Kelly Ha, et al.


  • Open Access

    Magnetic bioassembly platforms towards the generation of extracellular vesicles from human salivary gland functional organoids for epithelial repair

    by Ajjima Chansaenroj, Christabella Adine, Sawanya Charoenlappanit, Sittiruk Roytrakul, Ladawan Sariya, Thanaphum Osathanon, Sasitorn Rungarunlert, Ganokon Urkasemsin, Risa Chaisuparat, Supansa Yodmuang, et al.

    Salivary glands (SG) are exocrine organs with secretory units commonly injured by radiotherapy. Bio-engineered organoids and extracellular vesicles (EV) are currently under investigation as potential strategies for SG repair. Herein, three-dimensional (3D) cultures of SG functional organoids (SGo) and human dental pulp stem cells (hDPSC) were generated by magnetic 3D bioassembly (M3DB) platforms. Fibroblast growth factor 10 (FGF10) was used to enrich the SGo in secretory epithelial units. After 11 culture days via M3DB, SGo displayed SG-specific acinar epithelial units with functional properties upon neurostimulation. To consistently develop 3D hDPSC in vitro, 3 culture days were sufficient to maintain hDPSC undifferentiated genotype and phenotype for EV generation. EV isolation was performed via sequential centrifugation of the conditioned media of hDPSC and SGo cultures. EV were characterized by nanoparticle tracking analysis, electron microscopy and immunoblotting. EV were in the exosome range for hDPSC (diameter: 88.03 ± 15.60 nm) and for SGo (123.15 ± 63.06 nm). Upon ex vivo administration, exosomes derived from SGo significantly stimulated epithelial growth (up to 60%), mitosis, epithelial progenitors and neuronal growth in injured SG; however, such biological effects were less distinctive with the ones derived from hDPSC. Next, these exosome biological effects were investigated by proteomic arrays. Mass spectrometry profiling of SGo exosomes predicted that cellular growth, development and signaling was due to known and undocumented molecular targets downstream of FGF10. Semaphorins were identified as one of the novel targets requiring further investigations. Thus, M3DB platforms can generate exosomes with potential to ameliorate SG epithelial damage.


  • Engineering stromal heterogeneity in cancer

    by Leon Jia Wei Tang, Ayshath Zaseela, Clarissa Chin Min Toh, Christabella Adine, Abdullah Omer Aydar, N Gopalakrishna Iyer, Eliza Li Shan Fong


  • Hot or cold: Bioengineering immune contextures into in vitro patient-derived tumor models

    by Nathaniel Sheng Hua Too, Nicholas Ching Wei Ho, Christabella Adine, N Gopalakrishna Iyer, Eliza Li Shan Fong


  • Open Access

    Localized Delivery of Pilocarpine to Hypofunctional Salivary Glands through Electrospun Nanofiber Mats: An Ex Vivo and In Vivo Study

    by Sujatha Muthumariappan, Wei Cheng Ng, Christabella Adine, Kiaw Kiaw Ng, Pooya Davoodi, Chi-Hwa Wang, Joao N. Ferreira

    Dry mouth or xerostomia is a frequent medical condition among the polymedicated elderly population. Systemic pilocarpine is included in the first line of pharmacological therapies for xerostomia. However, the efficacy of existing pilocarpine formulations is limited due to its adverse side effects and multiple daily dosages. To overcome these drawbacks, a localized formulation of pilocarpine targeting the salivary glands (SG) was developed in the current study. The proposed formulation consisted of pilocarpine-loaded Poly(lactic-co-glycolic acid) (PLGA)/poly(ethylene glycol) (PEG) nanofiber mats via an electrospinning technique. The nanofiber mats were fully characterized for their size, mesh porosity, drug encapsulation efficiency, and in vitro drug release. Mat biocompatibility and efficacy was evaluated in the SG organ ex vivo, and the expression of proliferation and pro-apoptotic markers at the cellular level was determined. In vivo short-term studies were performed to evaluate the saliva secretion after acute SG treatment with pilocarpine-loaded nanofiber mats, and after systemic pilocarpine for comparison purposes. The outcomes demonstrated that the pilocarpine-loaded mats were uniformly distributed (diameter: 384 ± 124 nm) in a highly porous mesh, and possessed a high encapsulation efficiency (~81%). Drug release studies showed an initial pilocarpine release of 26% (4.5 h), followed by a gradual increase (~46%) over 15 d. Pilocarpine-loaded nanofiber mats supported SG growth with negligible cytotoxicity and normal cellular proliferation and homeostasis. Salivary secretion was significantly increased 4.5 h after intradermal SG treatment with drug-loaded nanofibers in vivo. Overall, this study highlights the strengths of PLGA/PEG nanofiber mats for the localized daily delivery of pilocarpine and reveals its potential for future clinical translation in patients with xerostomia.


  • A magnetic three‐dimensional levitated primary cell culture system for the development of secretory salivary gland‐like organoids

    by Joao N. Ferreira, Riasat Hasan, Ganokon Urkasemsin, Kiaw K. Ng, Christabella Adine, Sujatha Muthumariappan, Glauco R. Souza

    Salivary gland (SG) hypofunction and oral dryness can be induced by radiotherapy for head and neck cancers or auto‐immune disorders. These are common clinical conditions that involve loss of saliva‐secreting epithelial cells. Several oral complications arise with SG hypofunction that interfere with routine daily activities like chewing, swallowing and speaking. Hence, there is a need for replacing these saliva‐secreting cells. Recently, researchers have proposed to repair SG hypofunction via various cell‐based approaches in three‐dimensional (3D) scaffold‐based systems. However, majority of the scaffolds used cannot be translated clinically due to the presence of nonhuman‐based substrates. Herein, saliva‐secreting organoids/mini‐glands were developed using a new scaffold/substrate‐free culture system named magnetic 3D levitation (M3DL), which assembles and levitates magnetized primary SG‐derived cells (SGDC), allowing them to produce their own extracellular matrices. Primary SGDC were assembled in M3DL to generate SG‐like organoids in well‐established SG epithelial differentiation conditions for 7 days. After such culture time, these organoids consistently presented uniform spheres with greater cell viability and pro‐mitotic cells, when compared to conventional salisphere cultures. Additionally, organoids formed by M3DL expressed SG‐specific markers from different cellular compartments: acinar epithelial including adherens junctions (NKCC1, Cholinergic muscarinic receptor type 3, E‐cadherin, EpCAM); ductal epithelial and myoepithelial (Cytokeratin 14, α‐Smooth muscle actin), and neuronal (β3‐tubulin, Vesicular acetylcholine transferase). Lastly, intracellular calcium and α‐amylase activity assays showed functional organoids with SG‐specific secretory activity upon cholinergic stimulation. Thus, the functional organoid produced herein indicate that this M3DL system can be a promising tool to generate SG‐like mini‐glands for SG secretory repair.


  • Open Access

    Concise Review: Salivary Gland Regeneration: Therapeutic Approaches from Stem Cells to Tissue Organoids

    by Isabelle Lombaert, Mohammad M. Movahednia, Christabella Adine, Joao N. Ferreira

    The human salivary gland (SG) has an elegant architecture of epithelial acini, connecting ductal branching structures, vascular and neuronal networks that together function to produce and secrete saliva. This review focuses on the translation of cell‐ and tissue‐based research toward therapies for patients suffering from SG hypofunction and related dry mouth syndrome (xerostomia), as a consequence of radiation therapy or systemic disease. We will broadly review the recent literature and discuss the clinical prospects of stem/progenitor cell and tissue‐based therapies for SG repair and/or regeneration. Thus far, several strategies have been proposed for the purpose of restoring SG function: (1) transplanting autologous SG‐derived epithelial stem/progenitor cells; (2) exploiting non‐epithelial cells and/or their bioactive lysates; and (3) tissue engineering approaches using 3D (three‐dimensional) biomaterials loaded with SG cells and/or bioactive cues to mimic in vivo SGs. We predict that further scientific improvement in each of these areas will translate to effective therapies toward the repair of damaged glands and the development of miniature SG organoids for the fundamental restoration of saliva secretion. Stem Cells 2017;35:97–105


  • Open Access

    Three‐Dimensional Bioprinting Nanotechnologies towards Clinical Application of Stem Cells and Their Secretome in Salivary Gland Regeneration

    by Joao N Ferreira, Sasitorn Rungarunlert, Ganokon Urkasemsin, Christabella Adine, Glauco R Souza

    Salivary gland (SG) functional damage and severe dry mouth (or xerostomia) are commonly observed in a wide range of medical conditions from autoimmune to metabolic disorders as well as after radiotherapy to treat specific head and neck cancers. No effective therapy has been developed to completely restore the SG functional damage on the long‐term and reverse the poor quality of life of xerostomia patients. Cell‐ and secretome‐based strategies are currently being tested in vitro and in vivo for the repair and/or regeneration of the damaged SG using (1) epithelial SG stem/progenitor cells from salispheres or explant cultures as well as (2) nonepithelial stem cell types and/or their bioactive secretome. These strategies will be the focus of our review. Herein, innovative 3D bioprinting nanotechnologies for the generation of organotypic cultures and SG organoids/mini‐glands will also be discussed. These bioprinting technologies will allow researchers to analyze the secretome components and extracellular matrix production, as well as their biofunctional effects in 3D mini‐glands ex vivo. Improving our understanding of the SG secretome is critical to develop effective secretome‐based therapies towards the regeneration and/or repair of all SG compartments for proper restoration of saliva secretion and flow into the oral cavity.